Our measurements demonstrate substantial between-tumor variation in expression ratios of these proteins and suggest that PD-L2 is present in some tumors at levels sufficient to contribute to PD-1-dependent T-cell regulation and possibly to affect responses to PD-1- and PD-L1-blocking drugs. Here, CD274 is linked to neoplasm.